dog |
LD50 |
intravenous |
400mg/kg (400mg/kg) |
cardiac: change in rate vascular: bp lowering not characterized in autonomic section kidney, ureter, and bladder: changes in blood vessels or in circulation of kidney |
Journal of Cardiovascular Pharmacology. Vol. 3, Pg. 455, 1981. |
dog |
LD50 |
oral |
> 2gm/kg (2000mg/kg) |
|
Drugs of the Future. Vol. 7, Pg. 382, 1982. |
mouse |
LD50 |
intraperitoneal |
362mg/kg (362mg/kg) |
|
Drugs of the Future. Vol. 7, Pg. 382, 1982. |
mouse |
LD50 |
intravenous |
162mg/kg (162mg/kg) |
|
Drugs of the Future. Vol. 7, Pg. 382, 1982. |
mouse |
LD50 |
oral |
825mg/kg (825mg/kg) |
|
Drugs of the Future. Vol. 7, Pg. 382, 1982. |
mouse |
LD50 |
subcutaneous |
1420mg/kg (1420mg/kg) |
sense organs and special senses: ptosis: eye behavioral: altered sleep time (including change in righting reflex) lungs, thorax, or respiration: dyspnea |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 3839, 1987. |
rat |
LD50 |
intraperitoneal |
440mg/kg (440mg/kg) |
|
Drugs of the Future. Vol. 7, Pg. 382, 1982. |
rat |
LD50 |
intravenous |
269mg/kg (269mg/kg) |
cardiac: change in rate vascular: bp lowering not characterized in autonomic section |
Journal of Cardiovascular Pharmacology. Vol. 3, Pg. 455, 1981. |
rat |
LD50 |
oral |
2060mg/kg (2060mg/kg) |
cardiac: change in rate vascular: bp lowering not characterized in autonomic section |
Journal of Cardiovascular Pharmacology. Vol. 3, Pg. 455, 1981. |
rat |
LD50 |
subcutaneous |
> 2gm/kg (2000mg/kg) |
sense organs and special senses: ptosis: eye behavioral: altered sleep time (including change in righting reflex) liver: other changes |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 3839, 1987 |